Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
initial public offering
Pharma
Visen Pharmaceuticals files for $86M IPO in Hong Kong
Visen is designed to develop and commercialize Ascendis’ endocrinology therapies in greater China.
Gabrielle Masson
Mar 21, 2025 7:05am
AstraZeneca, Takeda, BioNTech—Fierce Pharma Asia
Nov 10, 2023 8:05am
Schott has carved out a standalone business for its pharma unit
Aug 1, 2022 3:14pm
Hansoh, J&J, Brii and more—Fierce Pharma Asia
Oct 22, 2021 5:46am
Cingulate seeks $58M to develop extended-release ADHD drugs
Sep 14, 2021 7:35am
Stevanato IPO raises $672M to fund biologics, vaccine delivery
Jul 20, 2021 8:20am
